神经退行性疾病的分子病理学
Sjors H W Scheres1, Benjamin Ryskeldi-Falcon2, Michel Goedert3
1Medical Research Council Laboratory of Molecular Biology, Cambridge, UK. scheres@mrc-lmb.cam.ac.uk.
Nature
|September 27, 2023
概括
特定的粉样蛋白结构,如tau和β粉样蛋白, 定义神经退行性疾病. 通过冷EM揭示原子结构, 帮助人们了解疾病,
科学领域:
- 神经科学
- 生物化学
- 结构生物学
背景情况:
- 大多数人类神经退行性疾病的特征是蛋白质的异常聚合,如tau,α-synuclein,TDP-43,和粉样蛋白-β变成粉样蛋白丝.
- 遗传因素直接将蛋白丝形成与疾病病因联系起来.
- 电子显微镜 (cryo-EM) 的进步使得人类大脑组织中的粉样蛋白在原子水平上的结构确定成为可能.
研究的目的:
- 审查到目前为止确定的大脑衍生性粉体纤维的原子结构.
- 讨论这些结构对神经退行研究的影响.
- 突出特定的粉样在定义不同疾病中的作用.
主要方法:
- 对冷电子显微镜 (cryo-EM) 研究的审查.
- 分析死后人类大脑中的粉样纤维的原子结构.
- 特定蛋白质结构与神经病理的相关性.
主要成果:
- 一个单一的蛋白质可以形成多种类型的粉丝结构.
- 特定的神经退行性疾病的特征是明显的粉样.
- 粉状结构提供了神经病理学的原子层次描述.
结论:
- 粉样结构为理解和研究神经退行性疾病提供了基本基础.
- 未来的研究应该利用模拟疾病相关的粉样结构的模型系统.
- 了解这些结构对于开发改善神经退行性疾病的诊断和治疗至关重要.
更多相关视频
10:04Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
Published on: October 20, 2017
13.5K
10:10Use of Two Dimensional Semi-denaturing Detergent Agarose Gel Electrophoresis to Confirm Size Heterogeneity of Amyloid or Amyloid-like Fibers
Published on: April 26, 2018
9.9K
相关概念视频
Cryo-electron Microscopy
3.4K
Conventional electron microscopy (EM) involves dehydration, fixation, and staining of biological samples, which distorts the native state of biological molecules and results in several artifacts. Also, the high-energy electron beam damages the sample and makes it difficult to obtain high-resolution images. These issues can be addressed using cryo-EM, which uses frozen samples and gentler electron beams. The technique was developed by Jacques Dubochet, Joachim Frank, and Richard Henderson, for...
3.4K
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Alzheimer's Disease: Overview
513
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
513
